tetano
Editor, Senior Moderator
Neurol Clin Neurosci
. 2022 May;10(3):178-180.
doi: 10.1111/ncn3.12594. Epub 2022 Mar 26.
A case of restless legs syndrome after BNT162b2 mRNA COVID-19 vaccination
Hisashi Ito[SUP] 1 [/SUP], Takahiro Kuroki[SUP] 1 [/SUP], Shigeto Horiuchi[SUP] 2 [/SUP], Yuichi Shinya[SUP] 3 [/SUP]
Affiliations
Abstract
Restless legs syndrome (RLS) can be secondary to several disorders. We present an 87-year-old woman who developed RLS 2 days after the first injection of BNT162b2 mRNA coronavirus disease 2019 vaccine. The symptoms of RLS tended to improve and eventually resolved with the administration of gabapentin.
Keywords: BNT162b2 mRNA vaccination COVID‐19; COVID‐19; restless legs syndrome; sleep‐related movement disorder.
. 2022 May;10(3):178-180.
doi: 10.1111/ncn3.12594. Epub 2022 Mar 26.
A case of restless legs syndrome after BNT162b2 mRNA COVID-19 vaccination
Hisashi Ito[SUP] 1 [/SUP], Takahiro Kuroki[SUP] 1 [/SUP], Shigeto Horiuchi[SUP] 2 [/SUP], Yuichi Shinya[SUP] 3 [/SUP]
Affiliations
- PMID: 35602174
- PMCID: PMC9115277
- DOI: 10.1111/ncn3.12594
Abstract
Restless legs syndrome (RLS) can be secondary to several disorders. We present an 87-year-old woman who developed RLS 2 days after the first injection of BNT162b2 mRNA coronavirus disease 2019 vaccine. The symptoms of RLS tended to improve and eventually resolved with the administration of gabapentin.
Keywords: BNT162b2 mRNA vaccination COVID‐19; COVID‐19; restless legs syndrome; sleep‐related movement disorder.